Code | 20653 | ||||||||||
MA number | 20/0435/10-S | ||||||||||
Product Form: | sol ijf 10x2 ml/4 mg (amp.skl.) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
Therapeutic Class: | 20 - ANTIEMETICA, ANTIVERTIGINOSA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | glass ampoule | ||||||||||
Route of admin.: | Intramuscular or intravenous use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 24.06.2010 |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
Pediatric warnings: | Yes |
SPC: | SPC_Ondansetron Accord 2 mg_ml injekčný alebo infúzny roztok_01_2020.doc |
PIL: | PIL_Ondansetron Accord 2 mg_ml injekčný alebo infúzny roztok_04_2022.pdf |
Safety feature | Yes |
Data update: | 13.03.2018 |